Skip to content
Search

Latest Stories

Catching up on sleep over weekends may reduce heart disease risk – new study finds

Catching up on sleep over weekends may reduce heart disease risk – new study finds

People who have the most 'catch-up' sleep on weekends have a significantly lower risk of developing heart disease than those with the least

Getting a good night's sleep is crucial for maintaining both physical and mental health, alongside a balanced diet and regular exercise.


Chronic sleep deprivation has been linked to an increased risk of serious conditions like diabetes and heart disease.

So, if you’re sleep deprived during weekdays, try to make up for it by getting extra sleep on weekends.

A new study has revealed catching up with compensatory sleep on weekends can significantly reduce the risk of heart disease.

The study conducted by the National Centre for Cardiovascular Disease in Beijing, China, found that individuals who catch up on sleep over the weekend may lower their risk of heart disease by one-fifth.

Study co-author Yanjun Song from the State Key Laboratory of Infectious Disease at Fuwai Hospital emphasised that the benefit of compensatory sleep was even more pronounced among individuals who regularly experience inadequate sleep on weekdays.

The researchers used data from 90,903 subjects involved in the UK Biobank project to evaluate the relationship between compensated weekend sleep and heart disease.

More than 21 per cent of the participants were identified as sleep-deprived – defined as getting less than seven hours of sleep per night.

After following up with the participants for almost 14 years, it was found that those who managed to get the most compensatory sleep (1.28 to 16.06 hours) had a 19 per cent lower risk of developing heart disease compared to those with the least ( -16.05 hours to -0.26 hours).

Among participants who experienced regular sleep deprivation during the week, those with the most compensatory sleep on weekends had a 20 per cent reduction in heart disease risk than those with the least.

Co-author Zechen Liu, also from Fuwai Hospital, noted that the findings underscore the importance of catching up on sleep for those who regularly suffer from sleep deprivation

"Our results show that for the significant proportion of the population in modern society that suffers from sleep deprivation, those who have the most 'catch-up' sleep at weekends have significantly lower rates of heart disease than those with the least,” he said.

The study findings were presented at ESC Congress 2024.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less